Caroline Pixberg1, Raphael Koch2, Hans Theodor Eich3, Ulla Martinsson4, Ingrid Kristensen5, Christiane Matuschek6, Rolf-Dieter Kortmann7, Fabian Pohl8, Khaled Elsayad1, Hans Christiansen9, Normann Willich1, Jack Lindh10, Diana Steinmann11. 1. Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany. 2. Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany. 3. Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany; Department of Radiation Oncology, University of Koeln, Koeln, Germany. Electronic address: Hans.Eich@ukmuenster.de. 4. Department of Oncology, University Hospital, Uppsala, Sweden. 5. Department of Radiation Physics, Skåne University Hospital, Lund, Sweden. 6. Department of Radiation Oncology, University Hospital of Duesseldorf, Duesseldorf, Germany. 7. Department of Radiation Oncology, University Hospital of Leipzig, Leipzig, Germany. 8. Department of Radiation Oncology, University of Regensburg, Regensburg, Germany. 9. Department of Radiation Oncology, Medical School Hannover, Hannover, Germany. 10. Department of Radiation Sciences, Umeå University, Umeå, Sweden. 11. Department of Radiation Oncology, University Hospital of Muenster, Muenster, Germany; Department of Radiation Oncology, Medical School Hannover, Hannover, Germany.
Abstract
PURPOSE: In the context of oncologic therapy for children, radiation therapy is frequently indicated. This study identified the frequency of and reasons for the development of high-grade acute toxicity and possible sequelae. MATERIALS AND METHODS: Irradiated children have been prospectively documented since 2001 in the Registry for the Evaluation of Side Effects After Radiation in Childhood and Adolescence (RiSK) database in Germany and since 2008 in the registry for radiation therapy toxicity (RADTOX) in Sweden. Data were collected using standardized, published forms. Toxicity classification was based on Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer criteria. RESULTS: As of June 2013, 1500 children have been recruited into the RiSK database and 485 into the RADTOX registry leading to an analysis population of 1359 patients (age range 0-18). A total of 18.9% (n=257) of all investigated patients developed high-grade acute toxicity (grades 3/4). High-grade toxicity of the bone marrow was documented for 63.8% (n=201) of those patients, oral mucositis for 7.6% (n=24), and dermatitis for 7.6% (n=24). Patients with high-grade acute toxicity received concomitant chemotherapy more frequently (56%) than patients with no or lower acute toxicity (31.5%). In multivariate analyses, concomitant chemotherapy, diagnosis of Ewing sarcoma, and total radiation dose showed a statistically noticeable effect (P≤.05) on acute toxicity, whereas age, concomitant chemotherapy, Hodgkin lymphoma, Ewing sarcoma, total radiation dose, and acute toxicity influenced the time until maximal late toxicity. CONCLUSIONS: Generally, high-grade acute toxicity after irradiation in children and adolescence occurs in a moderate proportion of patients (18.9%). As anticipated, the probability of acute toxicity appeared to depend on the prescribed dose as well as concomitant chemotherapy. The occurrence of chronic toxicity correlates with the prior acute toxicity grade. Age seems to influence the time until maximal late toxicity but not the development of acute toxicity.
PURPOSE: In the context of oncologic therapy for children, radiation therapy is frequently indicated. This study identified the frequency of and reasons for the development of high-grade acute toxicity and possible sequelae. MATERIALS AND METHODS: Irradiated children have been prospectively documented since 2001 in the Registry for the Evaluation of Side Effects After Radiation in Childhood and Adolescence (RiSK) database in Germany and since 2008 in the registry for radiation therapy toxicity (RADTOX) in Sweden. Data were collected using standardized, published forms. Toxicity classification was based on Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer criteria. RESULTS: As of June 2013, 1500 children have been recruited into the RiSK database and 485 into the RADTOX registry leading to an analysis population of 1359 patients (age range 0-18). A total of 18.9% (n=257) of all investigated patients developed high-grade acute toxicity (grades 3/4). High-grade toxicity of the bone marrow was documented for 63.8% (n=201) of those patients, oral mucositis for 7.6% (n=24), and dermatitis for 7.6% (n=24). Patients with high-grade acute toxicity received concomitant chemotherapy more frequently (56%) than patients with no or lower acute toxicity (31.5%). In multivariate analyses, concomitant chemotherapy, diagnosis of Ewing sarcoma, and total radiation dose showed a statistically noticeable effect (P≤.05) on acute toxicity, whereas age, concomitant chemotherapy, Hodgkin lymphoma, Ewing sarcoma, total radiation dose, and acute toxicity influenced the time until maximal late toxicity. CONCLUSIONS: Generally, high-grade acute toxicity after irradiation in children and adolescence occurs in a moderate proportion of patients (18.9%). As anticipated, the probability of acute toxicity appeared to depend on the prescribed dose as well as concomitant chemotherapy. The occurrence of chronic toxicity correlates with the prior acute toxicity grade. Age seems to influence the time until maximal late toxicity but not the development of acute toxicity.
Authors: Khaled Elsayad; Jan Kriz; Laith Samhouri; Uwe Haverkamp; Ronald Straeter; Walter Stummer; Hans Theodor Eich Journal: Strahlenther Onkol Date: 2016-06-07 Impact factor: 3.621
Authors: Rafaela Maia Almendra Mattos; Regina Maria Holanda de Mendonça; Simone Dos Santos Aguiar Journal: Support Care Cancer Date: 2019-05-23 Impact factor: 3.603
Authors: Clemens Seidel; André O von Bueren; Sabrina Bojko; Marion Hoffmann; Torsten Pietsch; Gerrit H Gielen; Monika Warmuth-Metz; Brigitte Bison; Rolf-D Kortmann; Christof M Kramm Journal: Strahlenther Onkol Date: 2017-10-11 Impact factor: 3.621